Evidence map›Paper›PMID 42287604›Full record

ArticleProbiotics and antimicrobial proteins2026

Peptide Analogs Isolated from Lactobacillus acidophilus Induce Multi-aggregate Formation and Impair Cell Division in Candida albicans.

Elias Jorge Muniz Seif, Ivan Novaski Avino, Ronaldo Zucatelli Mendonça, Pedro Ismael Silva Junior

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elias Jorge Muniz SeifLaboratory of Applied Toxicology, Center of Toxins, Immune-Response and Cell Signaling - CeT-ICS/CEPID, Butantan Institute, São Paulo, SP, CEP 05503-900, Brazil.ORCID http://orcid.org/0000-0001-9914-8897
Ivan Novaski AvinoLaboratory of Cell Cycle, Center of Toxins, Immune-Response and Cell Signaling - CeT-ICS/CEPID, Butantan Institute, São Paulo, SP, CEP 05503-900, Brazil.
Ronaldo Zucatelli MendonçaLaboratory of Parasitology, Butantan Institute São Paulo, São Paulo, SP, CEP 05503-900, Brazil.ORCID http://orcid.org/0000-0001-6661-5110
Pedro Ismael Silva JuniorLaboratory of Applied Toxicology, Center of Toxins, Immune-Response and Cell Signaling - CeT-ICS/CEPID, Butantan Institute, São Paulo, SP, CEP 05503-900, Brazil. pisjr@butantan.gov.br.ORCID http://orcid.org/0000-0001-6619-6489

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Yeasts of the Candida genus area major cause of infections regarding respiratory, digestive, and reproductive systems. Doderlin is an antimicrobial peptide isolated from Lactobacillus acidophilus and is notable for presenting a non-hemolytic effect. However, its long sequence and broad antimicrobial spectrum may limit its therapeutic applications. This study evaluated the antimicrobial activity, cytotoxicity, and morphofunctional effects of three Doderlin analogues (Dod H, Dod B, Dod T). Peptides were synthesized via Fmoc solid-phase synthesis. Antimicrobial activity and cellular effects were evaluated through growth assays, flow cytometry, and fluorescence and scanning electron microscopy. Among the analogues, Dod B exhibited the most promising antifungal activity, particularly against Candida albicans, while also inhibiting other clinically relevant Candida species, including Candida glabrata and Candida tropicalis. Notably, Dod B promoted the formation of interconnected cellular multi-aggregates and alterations in cellular physiology, potentially associated with interactions involving Seryl-tRNA synthetase (SerRS) and Peptidyl-prolyl isomerase ESS1. Although sequence optimization reduced the broad-spectrum activity observed for native Doderlin, it enhanced antifungal specificity and potency. These findings highlight Dod B as a promising therapeutic candidate for the treatment of Candida infections.

Indexed as

AntifungalDoderlinMitochondrial potentialMolecular dockingNecrosis and apoptosisPeptide synthesis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.